Champions Oncology
Quarterly Financials
| Values in thousands | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 |
|---|---|---|---|---|
Revenue | $13,836 | $16,559 | $15,035 | $13,995 |
Gross Profit | 7,027 | 7,725 | 7,773 | 6,000 |
EBITDA | -174 | 104 | 612 | -94 |
EBIT | -495 | -237 | 255 | -452 |
Net Income | -729 | -279 | 299 | -466 |
Net Change In Cash | 13,836 | 16,559 | 15,035 | 13,995 |
Free Cash Flow | -2,237 | -1,376 | -1,977 | 554 |
Cash | 4,872 | 7,127 | 8,516 | 10,325 |
Basic Shares | 13,832 | 13,886 | 14,457 | 13,788 |
Annual Financials
| Values in thousands | 2026-04-30 | 2025-04-30 | 2024-04-30 | 2023-04-30 |
|---|---|---|---|---|
Revenue | $59,425 | $56,944 | $50,155 | $53,870 |
Gross Profit | 28,525 | 28,555 | 20,754 | 24,338 |
EBITDA | 448 | 6,266 | -5,441 | -3,021 |
EBIT | -929 | 4,626 | -7,308 | -5,267 |
Net Income | -1,175 | 4,701 | -7,276 | -5,335 |
Net Change In Cash | 59,425 | 56,944 | 50,155 | 53,870 |
Cost of Revenue | 1,111 | |||
Free Cash Flow | -5,036 | 6,997 | -6,973 | 1,083 |
Cash | 4,872 | 9,785 | 2,618 | 10,118 |
Basic Shares | 13,832 | 14,266 | 13,547 | 13,541 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-04-30 | -$0.05 |
2026-01-31 | -$0.02 |
2025-10-31 | $0.06 |
2025-07-31 | $0.02 |